GlassScriptPhysician profile
Jenna D Oates
NPI 1013304468
$10,892.77
in general payments reported to CMS, 2019-2025
70 companies · $2,756 in 2025
The $2,756 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,206 · 2022: $1,911 · 2023: $2,586 · 2024: $2,434 · 2025: $2,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,576 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,575.98 |
| Education | $200.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,197.17 | 2021-2025 | |
| Incyte Corporation | $700.90 | 2021-2025 | Monjuvi, Jakafi, Pemazyre |
| Celgene Corporation | $612.13 | 2021-2025 | Reblozyl, Pomalyst |
| Janssen Biotech, INC. | $524.84 | 2021-2025 | Darzalex, Erleada, Tecvayli |
| Amgen INC. | $470.21 | 2021-2022 | |
| Pfizer INC. | $428.93 | 2021-2025 | |
| Genentech USA, INC. | $379.57 | 2023-2025 | Tecentriq, Venclexta, Polivy |
| E.R. Squibb & Sons, L.L.C. | $371.88 | 2021-2025 | Opdivo, Opdualag, Krazati |
| Regeneron Healthcare Solutions, INC. | $348.53 | 2021-2025 | Libtayo, Lynozyfic |
| Takeda Pharmaceuticals U.S.A., INC. | $339.69 | 2022-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Merck Sharp & Dohme LLC | $314.38 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Lilly USA, LLC | $301.45 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Abbvie INC. | $273.18 | 2022-2025 | |
| Exelixis INC. | $260.62 | 2021-2025 | Cabometyx |
| Genzyme Corporation | $256.59 | 2021-2025 |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $232.13 | 2021-2023 | Xospata |
| Astrazeneca Pharmaceuticals LP | $222.85 | 2021-2025 | Calquence, Lynparza, Enhertu |
| Beigene USA, INC. | $186.85 | 2021-2025 | Brukinsa |
| Array Biopharma INC | $185.60 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Eisai INC. | $183.96 | 2021-2025 | |
| Daiichi Sankyo INC. | $181.63 | 2021-2025 | Enhertu, Injectafer |
| Deciphera Pharmaceuticals INC. | $168.42 | 2021-2025 | Qinlock, Romvimza |
| Eagle Pharmaceuticals, INC. | $154.53 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $144.19 | 2021-2025 | Onivyde, Somatuline Depot |
| Myriad Genetic Laboratories, INC. | $141.15 | 2023 | Bracanalysis, Bracanalysis Cdx |
| Pharmaessentia USA Corporation | $136.51 | 2023-2025 | Besremi |
| Pharmacyclics LLC, An Abbvie Company | $127.42 | 2021-2023 | Imbruvica |
| Seagen INC. | $105.49 | 2021-2023 | Adcetris, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $104.54 | 2023-2025 | |
| Aveo Pharmaceuticals, INC. | $99.99 | 2022-2025 | |
| Glaxosmithkline, LLC. | $98.07 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Coherus Oncology, INC. | $94.32 | 2023-2025 | Loqtorzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.00 | 2025 | |
| Sumitomo Pharma America, INC. | $73.38 | 2023-2025 | Orgovyx |
| Beone Medicines USA, INC. | $68.83 | 2025 | Brukinsa |
| Kite Pharma, INC. | $66.32 | 2025 | Yescarta |
| Karyopharm Therapeutics INC. | $62.80 | 2021-2023 | Xpovio |
| Myovant Sciences INC. | $61.26 | 2021-2022 | |
| Spectrum Pharmaceuticals INC. | $59.08 | 2023-2024 | Rolvedon |
| Puma Biotechnology, INC. | $55.85 | 2023-2025 | |
| Sobi, INC | $55.22 | 2024-2025 | |
| Servier Pharmaceuticals LLC | $55.14 | 2024-2025 | |
| Pharmacosmos Therapeutics INC. | $54.37 | 2022-2025 | Monoferric |
| Blueprint Medicines Corporation | $52.37 | 2021-2023 | Ayvakit |
| Genmab U.S., INC. | $51.39 | 2023-2025 | Epkinly |
| Emd Serono, INC. | $51.23 | 2021-2024 | Bavencio |
| Jazz Pharmaceuticals INC. | $45.10 | 2025 | |
| Tersera Therapeutics LLC | $44.99 | 2023-2025 | Quzyttir |
| Gilead Sciences, INC. | $42.96 | 2025 | Trodelvy |
| Agios Pharmaceuticals, INC. | $42.34 | 2024-2025 | Pyrukynd |
| Fennec Pharmaceuticals, INC. | $40.33 | 2025 | Fyarro |
| Acceleron Pharma, INC. | $39.40 | 2021 | |
| G1 Therapeutics, INC. | $38.51 | 2022-2023 | Cosela |
| Progenics Pharmaceuticals, INC. | $34.32 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $34.02 | 2023-2024 | Provenge |
| Hema Biologics, LLC | $33.60 | 2023 | Sevenfact |
| Acrotech Biopharma INC. | $32.24 | 2024-2025 | Beleodaq |
| Taiho Oncology, INC. | $30.80 | 2022-2024 | |
| Morphosys, US INC. | $29.98 | 2022 | |
| Immunogen, INC. | $25.14 | 2023 | Elahere |
| Geron Corporation | $24.68 | 2025 | Rytelo |
| Kyowa Kirin, INC. | $23.60 | 2025 | |
| Adc Therapeutics America, INC. | $19.76 | 2023 | |
| Amneal Pharmaceuticals LLC | $18.69 | 2025 | Alymsys |
| Mirati Therapeutics, INC. | $17.93 | 2024 | Krazati |
| Syndax Pharmaceuticals, INC. | $17.69 | 2025 | |
| Telix Pharmaceuticals | $15.57 | 2025 | Illuccix |
| Azurity Pharmaceuticals, INC. | $15.43 | 2025 | Danziten |
| Stemline Therapeutics INC. | $13.21 | 2023 | Orserdu |
| Iovance Biotherapeutics, INC. | $11.52 | 2025 | Amtagvi |
Drugs and devices associated with these payments
Scemblix $266Reblozyl $263Libtayo $263Keytruda $232Monjuvi $231Imbruvica $205Brukinsa $190Tecentriq $190Opdivo $189Enhertu $184Verzenio $182Jaypirca $182Kisqali $175Sarclisa $170Braftovi $168Lynparza $165Darzalex $162Erleada $159Pemfexy $155Jakafi $152Venclexta $147Besremi $137Tecvayli $128Pemazyre $123Talvey $123Lenvima $122Xtandi $120Epkinly $119Mektovi $118Qinlock $112Tukysa $111Fruzaqla $110Cabometyx $109Pluvicto $107Onivyde $103Pomalyst $102Bracanalysis $99.89Akeega $97.54Adcetris $96.64Ninlaro $96.00Lorbrena $94.30Elahere $94.26Zynyz $88.81Balversa $88.02Tasigna $85.38Fotivda $84.06Elrexfio $74.25Orgovyx $73.38Nubeqa $67.40Yescarta $66.32Opdualag $63.38Padcev $63.23Bosulif $60.96Xalkori $60.45Rolvedon $59.08Piqray $58.34Somatuline Depot $57.25Polivy $56.45Stivarga $56.36Vitrakvi $56.36Doptelet $55.22Loqtorzi $54.42Xofigo $48.18Fabhalta $46.04Quzyttir $44.99Welireg $44.14Romvimza $43.93Mekinist $43.34Trodelvy $42.96Calquence $42.77Promacta $42.44Pyrukynd $42.34Bracanalysis Cdx $41.26Fyarro $40.33Udenyca $39.90Monoferric $39.81Retevmo $37.55Ibrance $37.46Ojjaara $36.87Krazati $36.87Inlyta $35.74Xpovio $35.14Provenge $34.02Columvi $33.81Lunsumio $33.81Alunbrig $33.67Sevenfact $33.60Beleodaq $32.24Illuccix $31.14Oxbryta $30.73Jemperli $29.36Tivdak $26.28Lynozyfic $25.35Wayrilz $25.32Rybrevant $24.99Rytelo $24.68Elitek $23.68Poteligeo $23.60Zepzelca $23.23Injectafer $21.96
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Oates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.